NCT07381179 Voices: Messages of Wisdom and Hope in the Face of Illness
| NCT ID | NCT07381179 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-11-13 |
| Primary Completion | 2027-12-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-11-13 with a primary completion date of 2027-12-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study may help doctors determine where patients and caregivers may need more support and identify ways to maintain patient and caregiver dignity while undergoing treatment.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of chronic or progressive illness with a primary caregiver, should patient wish to involve one * Willing and able to participate in a semi-structured recording lasting approximately 60 minutes. Dyad recordings conducted for participants who elect to involve a caregiver * Willing and able to participate in a single follow-up recording. Dyad follow up recordings conducted for participants who elect to involve a caregiver Exclusion Criteria: * Uncontrolled and/or intercurrent illness which limits participation in study recording * Vulnerable populations: persons lacking capacity for understanding participation in this study
Contact & Investigator
Ugur Sener, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07381179 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematopoietic and Lymphatic System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07381179 currently recruiting?
Yes, NCT07381179 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT07381179 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07381179 clinical trial?
NCT07381179 is sponsored by Mayo Clinic. The principal investigator is Ugur Sener, MD at Mayo Clinic. The trial plans to enroll 40 participants.